Author

Andrew Mazzanti

Mount Sinai Hospital

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Brandon ChoiD· 1 shared Giacomo FurlaniD· 1 shared Kirti Mittal· 1 shared Linda Z. PenniD· 1 shared Mélissa Shen· 1 shared Miguel Ramalho‐SantosiD· 1 shared Peter LiniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Brandon ChoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CHD1 is a synthetic lethal vulnerability in MYC-driven breast cancer

Brandon Cho, Giacomo Furlan, Peter Lin, Mélissa Shen, Kirti Mittal, Andrew Mazzanti, Linda Z. Penn, Miguel Ramalho‐Santos

The paper identifies CHD1 as a synthetic lethal target in MYC-driven breast cancer, showing that its loss suppresses tumor growth and induces cell death in MYC-overexpressing models.

Oncogene · Mar 7, 2026Peer-reviewedCancer Biology